The Case for Sites Using Their Own Tech to Accelerate Research and Reduce Burden

About the Episode:  In this podcast, we discuss the topic of clinical sites shifting to using the own technologies in sponsored trials and how it can advance (and maintain the pace of) clinical research. Our guest, Bryan Spielman, Chief Growth Officer at Advarra lays out the current burden being faced by performing sponsor trials. Mr Spielman also talks about the work Advarra has led in bringing together sites, CROs and sponsors to brainstorm new solutions, and the path forward to encourage wider conversation, acceptance and adoption.   Key Takeaways: Identifying current burdens faced by sitesUnderstanding current attitudes towards site-owned technologySteps forward to benefit both sides of clinical research   About the Speaker:  Bryan Spielman, MBA, is Chief Growth Officer at Advarra and is responsible for driving Advarra’s corporate strategy, mergers and acquisitions, strategic partnerships, and corporate marketing. Spielman brings over 25 years of business development and corporate strategy experience from leading technology companies including those with a focus on life sciences.   For more information about innovation in clinical research, click here.